TrianglePUBLICATIONS · 16423847
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2006 Apr
- First author
- Marty M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Marty M
- type
- Author
- name
- Espié M
- type
- Author
- name
- Llombart A
- type
- Author
- name
- Monnier A
- type
- Author
- name
- Rapoport BL
- type
- Author
- name
- Stahalova V
- type
- Author
- name
- Dexrazoxane Study Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Marty M
- type
- Author
- name
- Espié M
- type
- Author
- name
- Llombart A
- type
- Author
- name
- Monnier A
- type
- Author
- name
- Rapoport BL
- type
- Author
- name
- Stahalova V
- type
- Author
- name
- Dexrazoxane Study Group
- type
- CollectiveName
- bibliography ids
- nci-bib-55203f8590d702893b308494
- book metadata
- content sha256
- 29a71176a5b7dde1425d439ade28f51adf20674994d3074cc5cf57977ce70330
- document type
- citation
- dois
- 10.1093/annonc/mdj134
- electronic publication date
- display
- 2006 Jan 19
- precision
- day
- year
- 2006
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16423847
- immutable id
- pubmed:16423847@29a71176a5b7dde1425d439ade28f51adf20674994d3074cc5cf57977ce70330
- journal
- abbreviation
- Ann Oncol
- issn electronic
- Source null
- issn print
- 0923-7534
- issue
- 4
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 614-22
- volume
- 17
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16423847
- provenance
- batch id
- a181c30258a88d182e78
- provider
- NCBI PubMed ESummary
- record sha256
- 1fbf60f86c60d9a8f385535681c949e522f014ff32754217710f73d6470c3d6c
- response sha256
- 558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
- retrieved at
- 2026-09-09T23:46:03.896343+00:00
- publication date
- display
- 2006 Apr
- precision
- month
- year
- 2006
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy.
Preserved source evidence · Not medical advice